T. Rowe Price Investment Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.41M | Sell |
76,943
-720,043
| -90% | -$22.5M | ﹤0.01% | 597 |
|
|
2025
Q1 | $26.7M | Sell |
796,986
-640,845
| -45% | -$21.5M | 0.02% | 482 |
|
|
2024
Q4 | $56.4M | Sell |
1,437,831
-65,977
| -4% | -$2.59M | 0.03% | 391 |
|
|
2024
Q3 | $59.2M | Buy |
1,503,808
+63,905
| +4% | +$2.52M | 0.04% | 377 |
|
|
2024
Q2 | $56.1M | Buy |
1,439,903
+13,564
| +1% | +$529K | 0.04% | 373 |
|
|
2024
Q1 | $61.4M | Buy |
1,426,339
+535,190
| +60% | +$23M | 0.04% | 360 |
|
|
2023
Q4 | $41M | Buy |
+891,149
| New | +$41M | 0.03% | 410 |
|